Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer
Clinical trial NCT01827267 · COMPLETED
Trial details
- NCT number
- NCT01827267
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2016-09-20
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.